Antipsychotic drugmakers target marketing dollars at D.C. Medicaid psychiatrists, study indicates
Wednesday, September 26, 2012 - 21:00
in Health & Medicine
The D.C. Department of Health has released a study by George Washington University School of Public Health & Health Services indicating the high levels of marketing by antipsychotic drug manufacturers to Medicaid psychiatrists in the District of Columbia.